L 696229结构式
|
常用名 | L 696229 | 英文名 | L 696229 |
|---|---|---|---|---|
| CAS号 | 135525-71-2 | 分子量 | 282.33700 | |
| 密度 | 1.149g/cm3 | 沸点 | 496.5ºC at 760mmHg | |
| 分子式 | C17H18N2O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 254.1ºC |
L 696229用途L 696229是人类免疫缺陷病毒1型(HIV-1)逆转录酶活性的特异性抑制剂,具有抗病毒活性。 |
| 英文名 | 3-[2-(1,3-benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-1H-pyridin-2-one |
|---|---|
| 英文别名 | 更多 |
| 密度 | 1.149g/cm3 |
|---|---|
| 沸点 | 496.5ºC at 760mmHg |
| 分子式 | C17H18N2O2 |
| 分子量 | 282.33700 |
| 闪点 | 254.1ºC |
| 精确质量 | 282.13700 |
| PSA | 59.15000 |
| LogP | 3.58440 |
| InChIKey | MHUVLRNBDLFMHQ-UHFFFAOYSA-N |
| SMILES | CCc1cc(CCc2nc3ccccc3o2)c(=O)[nH]c1C |
| 蒸汽压 | 5.37E-10mmHg at 25°C |
| 折射率 | 1.58 |
|
~93%
L 696229 135525-71-2 |
| 文献:Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925 |
|
~%
L 696229 135525-71-2 |
| 文献:Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925 |
|
~%
L 696229 135525-71-2 |
| 文献:Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925 |
|
~%
L 696229 135525-71-2 |
| 文献:Hoffman; Smith; Rooney; Fisher; Wai; Thomas; Bamberger; Barnes; Williams; Jones; Olson; O'Brien; Goldman; Nunberg; Quintero; Schleif; Emini; Anderson Journal of Medicinal Chemistry, 1993 , vol. 36, # 8 p. 953 - 966 |
|
~%
L 696229 135525-71-2 |
| 文献:Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925 |
|
~%
L 696229 135525-71-2 |
| 文献:Saari; Hoffman; Wai; Fisher; Rooney; Smith; Thomas; Goldman; O'Brien; Nunberg; Quintero; Schleif; Emini; Stern; Anderson Journal of Medicinal Chemistry, 1991 , vol. 34, # 9 p. 2922 - 2925 |
| L 696229上游产品 5 | |
|---|---|
| L 696229下游产品 0 | |
|
实验名称:Inhibitory activity against HIV-1 reverse transcriptase (RT)
来源:ChEMBL
靶标:Reverse transcriptase/RNaseH
External Id:CHEMBL800583
|
|
实验名称:Cell culture inhibitor concentration required to inhibit the spread of HIV-1 strain I...
来源:ChEMBL
靶标:Reverse transcriptase/RNaseH
External Id:CHEMBL712761
|
|
实验名称:Plasma equilibrium dissociation constant was determined
来源:ChEMBL
靶标:N/A
External Id:CHEMBL702850
|
|
实验名称:HIV-1 RT Assay from Article 10.1021/jm00113a036: "2-Pyridinone derivatives: a new cla...
来源:BindingDB
靶标:N/A
External Id:BindingDB_423_1
|
|
实验名称:Tested for inhibition against HIV-1 RT (used (poly)rC-(oligo)dG as the template)
来源:ChEMBL
靶标:Reverse transcriptase/RNaseH
External Id:CHEMBL800744
|
|
实验名称:In vitro inhibitory concentration against HIV-1 reverse transcriptase using rC-dG tem...
来源:ChEMBL
靶标:Reverse transcriptase/RNaseH
External Id:CHEMBL802761
|
|
实验名称:Percent unbound determined for whole normal human plasma
来源:ChEMBL
靶标:N/A
External Id:CHEMBL701453
|
| 3-[2-(Benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-pyridin-2(1H)-one |
| 2-pyridinol,3-[2-(2-benzoxazolyl)ethyl]-5-ethyl-6-methyl |
| 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methyl-2-(1H)-pyridinone |